- Home
- BSLK vs TXMD Comparison
BSLK vs TXMD Comparison
Compare BSLK & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSLK
- TXMD
- Stock Information
- Founded
- BSLK 2009
- TXMD 2008
- Country
- BSLK United States
- TXMD United States
- Employees
- BSLK N/A
- TXMD N/A
- Industry
- BSLK
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- BSLK
- TXMD Health Care
- Exchange
- BSLK NYSE
- TXMD Nasdaq
- Market Cap
- BSLK 16.0M
- TXMD 13.1M
- IPO Year
- BSLK N/A
- TXMD N/A
- Fundamental
- Price
- BSLK $0.36
- TXMD $1.16
- Analyst Decision
- BSLK
- TXMD
- Analyst Count
- BSLK 0
- TXMD 0
- Target Price
- BSLK N/A
- TXMD N/A
- AVG Volume (30 Days)
- BSLK 4.5M
- TXMD 18.0K
- Earning Date
- BSLK 11-07-2024
- TXMD 11-12-2024
- Dividend Yield
- BSLK N/A
- TXMD N/A
- EPS Growth
- BSLK N/A
- TXMD N/A
- EPS
- BSLK N/A
- TXMD N/A
- Revenue
- BSLK $1,489,000.00
- TXMD $1,596,000.00
- Revenue This Year
- BSLK N/A
- TXMD $605.07
- Revenue Next Year
- BSLK N/A
- TXMD $1.11
- P/E Ratio
- BSLK $0.08
- TXMD N/A
- Revenue Growth
- BSLK N/A
- TXMD N/A
- 52 Week Low
- BSLK $0.23
- TXMD $1.10
- 52 Week High
- BSLK $17.02
- TXMD $2.75
- Technical
- Relative Strength Index (RSI)
- BSLK N/A
- TXMD 29.78
- Support Level
- BSLK N/A
- TXMD $1.10
- Resistance Level
- BSLK N/A
- TXMD $1.30
- Average True Range (ATR)
- BSLK 0.00
- TXMD 0.06
- MACD
- BSLK 0.00
- TXMD -0.01
- Stochastic Oscillator
- BSLK 0.00
- TXMD 21.21
About BSLK BOLT PROJECTS HOLDINGS INC
Bolt Projects Holdings Inc formerly Golden Arrow Merger Corp is an shell company.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.